Down-regulated expression of NPM1 in IMS-M2 cell line by (-)-epigallocatechin-3-gallate
Asian Pacific Journal of Tropical Biomedicine
;
(12): 570-574, 2014.
Article
in English
| WPRIM
| ID: wpr-343196
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the inhibited effect of epigallocatechin-3-gallate (EGCG) on the expression of NPM1 in IMS-M2 cells harboring the NPM1 mutations.</p><p><b>METHODS</b>Cell proliferation assay was performed to test the effects of EGCG on cell growth of IMS-M2 cells harboring the NPM1 mutations. Western blot analysis were performed to test the protein expression of NPM1, AKT, those associated with apoptosis.</p><p><b>RESULTS</b>EGCG can down-regulate the expression of NPM1 in IMS-M2 cells harboring the NPM1 mutations. Moreover, EGCG also suppressed the cell proliferation and induced apoptosis in IMS-M2 cells.</p><p><b>CONCLUSIONS</b>The results suggested that EGCG could be considered as a reagent for treatment of AML patients with NPM1 mutations.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Asian Pacific Journal of Tropical Biomedicine
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS